Samrat Pharmachem Ltd
company logo

Samrat Pharmachem Ltd

Samrat Pharma Share Price

Pharmaceuticals
Small Cap

-

0 (0%)

Start Investing in Samrat Pharmachem Ltd

*By signing up you agree to our Terms and Conditions

Samrat Pharmachem Ltd Performance

-

-

-

-


-

-

-

-

-

Samrat Pharmachem Ltd Fundamentals

148.29Cr

41.02

2.28

0.21

11.70

0.21%

210.35

i buttonClick here to know more about Fundamentals

Samrat Pharmachem Ltd Financials

Samrat Pharmachem Ltd Financialsright-arrow

Samrat Pharmachem Ltd Shareholding Pattern

Samrat Pharmachem Ltd Delivery and Volume

About Samrat Pharmachem Ltd

Samrat Pharmachem Ltd was incorporated on June 16, 1992. The Company's principal activities are manufacturing and selling chemicals. The Company floated a new 100% subsidiary company during the year 2003-04 named as Samrat Remedies Limited to carry on activities of Manufacturing of Pharmaceutical

Lalit Mehta

1992

-

NameDesignation
Lalit MehtaChairman & Managing Director
Rajesh MehtaDirector & CFO
Mahendra PipaliaIndependent Director
Samir KotharyIndependent Director
Renu P DharodIndependent Director
Megh MehtaExecutive Director
Nishant KankariaCompany Sec. & Compli. Officer
News and Events...

Similar Stocks

What's Trending

View All
View All

Samrat Pharmachem Ltd FAQs

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Samrat Pharmachem Ltd shares in BlinkX.
The share price of any stock is volatile and changes during the day due to a variety of variables. Samrat Pharmachem Ltd's share price is ₹479.9 as of 2024-11-02.
Samrat Pharmachem Ltd's P/E ratio is 41.02 times as of 2024-11-02.
Samrat Pharmachem Ltd's most recent financial reports indicate a price-to-book ratio of 2.28, showing the company's stock market valuation in relation to the value of its real assets.
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Samrat Pharmachem Ltd's market capitalization is ₹148.29 Cr as on 2024-11-02.
The current financial records of Samrat Pharmachem Ltd show a 3.37% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
According to Samrat Pharmachem Ltd's most recent financial filings, the company has a total asset value of ₹103, which includes current and non-current assets such as inventory, cash, properties, and equipment.
The 52-week high/low price of a Samrat Pharmachem Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Samrat Pharmachem Ltd's 52-week high and low as of 2024-11-02 are ₹500 and ₹475, respectively.